John L. Green, CFO of Cogent Biosciences ($COGT), sold nearly $3 million in company shares on the open market once over the past year, with the latest sale on December 26, 2025. This ranks his total 2742nd among nearly 12,000 individual insiders, below the average sale amount of $8.6 million across 6.4 transactions. He made no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 26, 2025 | Cogent Biosciences, Inc. | $COGT | Green John L. | Chief Financial Officer | S | Common Stock | 77000 | $38.68 | 131,834.0000 | 142,376,529 | 36.87% | 0.05% |
| Dec. 17, 2025 | Cogent Biosciences, Inc. | $COGT | Green John L. | Chief Financial Officer | A | Common Stock | 50000 | $0.00 | 53,841.0000 | 142,376,529 | 1301.74% | 0.04% |
| Dec. 17, 2025 | Cogent Biosciences, Inc. | $COGT | Green John L. | Chief Financial Officer | A | Common Stock | 300000 | $0.00 | 353,841.0000 | 142,376,529 | 557.20% | 0.21% |
| Dec. 17, 2025 | Cogent Biosciences, Inc. | $COGT | Green John L. | Chief Financial Officer | F | Common Stock | 145007 | $39.45 | 208,834.0000 | 142,376,529 | 40.98% | 0.10% |
| Dec. 17, 2025 | Cogent Biosciences, Inc. | $COGT | Green John L. | Chief Financial Officer | A | Stock Option (Right to Buy) | 65000 | $0.00 | 65,000.0000 | 142,376,529 | 9999.99% | 0.05% |
| Jan. 23, 2025 | Cogent Biosciences, Inc. | $COGT | Green John L. | Chief Financial Officer | A | Stock Option (Right to Buy) | 270000 | $0.00 | 270,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Cogent Biosciences, Inc. | $COGT | Green John L. | Chief Financial Officer | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |